Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Share-based Compensation (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Share-based Compensation for 6 consecutive years, with $5.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Share-based Compensation rose 1.18% year-over-year to $5.0 million, compared with a TTM value of $26.1 million through Sep 2025, up 68.4%, and an annual FY2024 reading of $17.5 million, up 32.74% over the prior year.
  • Share-based Compensation was $5.0 million for Q3 2025 at Aveanna Healthcare Holdings, down from $5.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $11.0 million in Q1 2025 and bottomed at $712000.0 in Q2 2021.
  • Average Share-based Compensation over 5 years is $4.2 million, with a median of $4.1 million recorded in 2024.
  • The sharpest move saw Share-based Compensation soared 576.26% in 2022, then crashed 49.28% in 2023.
  • Year by year, Share-based Compensation stood at $712000.0 in 2021, then soared by 150.7% to $1.8 million in 2022, then surged by 68.85% to $3.0 million in 2023, then surged by 65.3% to $5.0 million in 2024, then decreased by 0.44% to $5.0 million in 2025.
  • Business Quant data shows Share-based Compensation for AVAH at $5.0 million in Q3 2025, $5.2 million in Q2 2025, and $11.0 million in Q1 2025.